Mark Hopman

Mark Hopman

Corporate Officer/Principal at BETA BIONICS, INC.

Net worth: 2 M $ as of 2026-05-30

48 year
Health Technology
Consumer Services
Technology Services

Profile

Mr. Mark Hopman is a Chief Commercial Officer at Beta Bionics, Inc. Mr. Hopman was previously employed as a Vice President-Market Access by Pear Therapeutics (US), Inc. and a Director-Retail Distribution by DexCom, Inc. He received his undergraduate degree from The Ohio State University College of Pharmacy and an MBA from Williams College of Business.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-06-23 129,354 ( 0.29% ) 2 M $ 2026-05-30
2025-01-28 0 ( -.--% ) - $ 2026-05-30

Mark Hopman active positions

CompaniesPositionStart
BETA BIONICS, INC. Corporate Officer/Principal 2023-02-28

Former positions of Mark Hopman

CompaniesPositionEnd
Corporate Officer/Principal 2023-02-28
DEXCOM, INC. Corporate Officer/Principal 2021-05-31
See the detail of Mark Hopman's experience

Training of Mark Hopman

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

18

1st degree connections

5

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies5

Health Technology

Consumer Services

Technology Services

Consumer Services

Health Technology